As the global economy recovers in 2021 and the supply of the industrial chain improves, the Cell and Gene Therapy market will undergo major changes. According to the latest research, the market size of the Cell and Gene Therapy industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Cell and Gene Therapy industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Cell and Gene Therapy market during the next few years. The global Cell and Gene Therapy market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
The Cell and Gene Therapy market can be split based on product types, major applications, and important regions as follows:
bluebird bio, Inc.
Dendreon Pharmaceuticals LLC.
Fibrocell Science, Inc.
Human Stem Cells Institute
Kite Pharma, Inc.
Kolon TissueGene, Inc.
Orchard Therapeutics plc.
Organogenesis Holdings Inc.
Shanghai Sunway Biotech Co., Ltd.,
Sibiono GeneTech Co. Ltd.,
Spark Therapeutics, Inc.
ViroMed Co., Ltd.
Other Therapeutic Classes
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)